| Bhavnit Bhatia, | |
|
2799 W Grand Blvd, Detroit, MI 48202-2608 | |
| (313) 916-2600 | |
| Not Available |
| Full Name | Bhavnit Bhatia |
|---|---|
| Gender | Female |
| Speciality | Dermatology |
| Experience | 9 Years |
| Location | 2799 W Grand Blvd, Detroit, Michigan |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1902292055 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207N00000X | Dermatology | 4301109534 (Michigan) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Permanente Medical Group Inc | 8921910225 | 7800 |
News Archive
Allos Therapeutics, Inc. today announced the presentation of initial data from COMPLETE, an international registry designed to address the urgent need for an increased understanding of the treatment patterns and outcomes for patients with peripheral T-cell lymphoma.
HHS should take action "soon to end a de facto form of discrimination" by rewriting its rules prohibiting HIV-positive people from visiting the U.S., a Washington Post editorial says, adding that the continuation of the policy "puts the United States in the company of countries such as Libya, Saudi Arabia and Sudan."
Sinovac Biotech Ltd. announced today that it begins the production of a vaccine against influenza A (H1N1) virus. The virus seed was received from U.S. CDC and was delivered to the company on June 8, 2009.
Isotechnika Pharma Inc. announces that the results of the CONFIRM1 clinical trial conducted by its medical device partner, Atrium Medical Corporation, were presented by Glenn Van Langenhove, MD, PhD (Middelheim Hospital in Antwerp, Belgium), the principal investigator, at the Transcatheter Cardiovascular Therapeutics (TCT) 2010 Scientific Symposium in Washington, DC last week.
› Verified 1 days ago
| Entity Name | Permanente Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1073606299 PECOS PAC ID: 8921910225 Enrollment ID: O20031104000710 |
News Archive
Allos Therapeutics, Inc. today announced the presentation of initial data from COMPLETE, an international registry designed to address the urgent need for an increased understanding of the treatment patterns and outcomes for patients with peripheral T-cell lymphoma.
HHS should take action "soon to end a de facto form of discrimination" by rewriting its rules prohibiting HIV-positive people from visiting the U.S., a Washington Post editorial says, adding that the continuation of the policy "puts the United States in the company of countries such as Libya, Saudi Arabia and Sudan."
Sinovac Biotech Ltd. announced today that it begins the production of a vaccine against influenza A (H1N1) virus. The virus seed was received from U.S. CDC and was delivered to the company on June 8, 2009.
Isotechnika Pharma Inc. announces that the results of the CONFIRM1 clinical trial conducted by its medical device partner, Atrium Medical Corporation, were presented by Glenn Van Langenhove, MD, PhD (Middelheim Hospital in Antwerp, Belgium), the principal investigator, at the Transcatheter Cardiovascular Therapeutics (TCT) 2010 Scientific Symposium in Washington, DC last week.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Bhavnit Bhatia, 2799 W Grand Blvd, Detroit, MI 48202-2608 Ph: (313) 916-2600 | Bhavnit Bhatia, 2799 W Grand Blvd, Detroit, MI 48202-2608 Ph: (313) 916-2600 |
News Archive
Allos Therapeutics, Inc. today announced the presentation of initial data from COMPLETE, an international registry designed to address the urgent need for an increased understanding of the treatment patterns and outcomes for patients with peripheral T-cell lymphoma.
HHS should take action "soon to end a de facto form of discrimination" by rewriting its rules prohibiting HIV-positive people from visiting the U.S., a Washington Post editorial says, adding that the continuation of the policy "puts the United States in the company of countries such as Libya, Saudi Arabia and Sudan."
Sinovac Biotech Ltd. announced today that it begins the production of a vaccine against influenza A (H1N1) virus. The virus seed was received from U.S. CDC and was delivered to the company on June 8, 2009.
Isotechnika Pharma Inc. announces that the results of the CONFIRM1 clinical trial conducted by its medical device partner, Atrium Medical Corporation, were presented by Glenn Van Langenhove, MD, PhD (Middelheim Hospital in Antwerp, Belgium), the principal investigator, at the Transcatheter Cardiovascular Therapeutics (TCT) 2010 Scientific Symposium in Washington, DC last week.
› Verified 1 days ago
Dr. Laurie Linden Kohen, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 3031 W Grand Blvd, Detroit, MI 48202 Phone: 313-916-2171 | |
James A Brown, MD Dermatology Medicare: Not Enrolled in Medicare Practice Location: 22151 Moross, Suite 234, Detroit, MI 48236 Phone: 313-885-5110 Fax: 313-885-8755 | |
David M. Ozog, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 3031 W Grand Blvd, Detroit, MI 48202 Phone: 313-916-2454 | |
Dr. Emily L. Keimig, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 3031 W Grand Blvd, Suite 800, Detroit, MI 48202 Phone: 313-916-2171 | |
Dr. Alison Tisack Boucher, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 3031 W Grand Blvd, Detroit, MI 48202 Phone: 313-916-2151 | |
Marsha L. Chaffins, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: Henry Ford Health System, 3031 West Grand Blvd., Detroit, MI 48202 Phone: 313-916-2454 | |
Dr. Snehal R Desai, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 3031 W Grand Blvd, Suite 800, Detroit, MI 48202 Phone: 313-916-2171 |